guest ::
| Home > Publications Database > New classification of tauopathies. > print |
| 001 | 140284 | ||
| 005 | 20240613151933.0 | ||
| 024 | 7 | _ | |a 10.1016/j.neurol.2018.07.001 |2 doi |
| 024 | 7 | _ | |a pmid:30098799 |2 pmid |
| 024 | 7 | _ | |a 0035-3787 |2 ISSN |
| 024 | 7 | _ | |a 2213-0004 |2 ISSN |
| 024 | 7 | _ | |a altmetric:70398201 |2 altmetric |
| 037 | _ | _ | |a DZNE-2020-06606 |
| 041 | _ | _ | |a English |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Höglinger, G. U. |0 P:(DE-2719)2811373 |b 0 |e First author |u dzne |
| 245 | _ | _ | |a New classification of tauopathies. |
| 260 | _ | _ | |a Issy-les-Moulineaux |c 2018 |b Elsevier Masson |
| 264 | _ | 1 | |3 print |2 Crossref |b Elsevier BV |c 2018-11-01 |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1718284726_11707 |2 PUB:(DE-HGF) |x Review Article |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 520 | _ | _ | |a Tauopathies are a group of neurodegenerative diseases characterized by pathological intracellular deposits of the protein tau. Isoform composition, morphology and anatomical distribution of cellular tau-immunoreactivities are defining distinct tauopathies as molecular pathological disease entities. The clinical spectrum of tauopathies includes syndromes with primary motor symptoms and with primary cognitive dysfunction. The traditional syndrome-based classification is currently being complemented by a molecular-pathological classification. While the syndrome-based classification is helpful to select symptomatic therapies, and to generate clinical working hypotheses about underlying etiologies, the molecular-pathological classification is most important for the development and application of molecularly tailored disease-modifying therapies. |
| 536 | _ | _ | |a 344 - Clinical and Health Care Research (POF3-344) |0 G:(DE-HGF)POF3-344 |c POF3-344 |f POF III |x 0 |
| 542 | _ | _ | |i 2018-11-01 |2 Crossref |u https://www.elsevier.com/tdm/userlicense/1.0/ |
| 588 | _ | _ | |a Dataset connected to CrossRef, PubMed, |
| 650 | _ | 2 | |a Humans |2 MeSH |
| 650 | _ | 2 | |a Neurodegenerative Diseases: classification |2 MeSH |
| 650 | _ | 2 | |a Neurodegenerative Diseases: genetics |2 MeSH |
| 650 | _ | 2 | |a Supranuclear Palsy, Progressive: classification |2 MeSH |
| 650 | _ | 2 | |a Supranuclear Palsy, Progressive: genetics |2 MeSH |
| 650 | _ | 2 | |a Supranuclear Palsy, Progressive: physiopathology |2 MeSH |
| 650 | _ | 2 | |a Tauopathies: classification |2 MeSH |
| 650 | _ | 2 | |a Tauopathies: genetics |2 MeSH |
| 650 | _ | 2 | |a Tauopathies: physiopathology |2 MeSH |
| 700 | 1 | _ | |a Respondek, G. |0 P:(DE-2719)2811600 |b 1 |u dzne |
| 700 | 1 | _ | |a Kovacs, G. G. |b 2 |
| 773 | 1 | 8 | |a 10.1016/j.neurol.2018.07.001 |b : Elsevier BV, 2018-11-01 |n 9 |p 664-668 |3 journal-article |2 Crossref |t Revue Neurologique |v 174 |y 2018 |x 0035-3787 |
| 773 | _ | _ | |a 10.1016/j.neurol.2018.07.001 |g Vol. 174, no. 9, p. 664 - 668 |0 PERI:(DE-600)2036356-4 |n 9 |q 174:9<664 - 668 |p 664-668 |t Revue neurologique |v 174 |y 2018 |x 0035-3787 |
| 856 | 4 | _ | |u https://pub.dzne.de/record/140284/files/DZNE-2020-06606_Restricted.pdf |
| 856 | 4 | _ | |u https://pub.dzne.de/record/140284/files/DZNE-2020-06606_Restricted.pdf?subformat=pdfa |x pdfa |
| 909 | C | O | |p VDB |o oai:pub.dzne.de:140284 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 0 |6 P:(DE-2719)2811373 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 1 |6 P:(DE-2719)2811600 |
| 913 | 1 | _ | |a DE-HGF |b Gesundheit |l Erkrankungen des Nervensystems |1 G:(DE-HGF)POF3-340 |0 G:(DE-HGF)POF3-344 |3 G:(DE-HGF)POF3 |2 G:(DE-HGF)POF3-300 |4 G:(DE-HGF)POF |v Clinical and Health Care Research |x 0 |
| 914 | 1 | _ | |y 2018 |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b REV NEUROL-FRANCE : 2021 |d 2022-11-25 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2022-11-25 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2022-11-25 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2022-11-25 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2022-11-25 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |d 2022-11-25 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1110 |2 StatID |b Current Contents - Clinical Medicine |d 2022-11-25 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |d 2022-11-25 |
| 915 | _ | _ | |a IF < 5 |0 StatID:(DE-HGF)9900 |2 StatID |d 2022-11-25 |
| 920 | 1 | _ | |0 I:(DE-2719)1110002 |k AG Höglinger 1 |l Translational Neurodegeneration |x 0 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a I:(DE-2719)1110002 |
| 980 | _ | _ | |a UNRESTRICTED |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|